Beta Drugs Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,180.10 -36.10 (-2.97%)Updated : 19 May 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	300.26	245.58	184.09	148.39
Other Net	1.08	0.13	-0.04	0.15
Diluted Weighted Average Shares	1.01	1.01	1.01	1.01
Depreciation/ Amortization	12.51	9.78	10.41	7.25
Total Extraordinary Items	-4.57	-	-	-
Operating Income	62.09	50.13	43.03	35.44
Net Income	42.42	36.44	30.72	24.83
Income Availableto Com Excl Extra Ord	46.99	36.44	30.72	24.83
Net Income Before Taxes	61.54	48.75	41.06	34.30
Net Income After Taxes	46.99	36.44	30.72	24.83
Income Availableto Com Incl Extra Ord	42.42	36.44	30.72	24.83
Costof Revenue Total	211.97	181.20	129.98	112.24
Gross Profit	150.38	114.52	97.13	71.60
Interest Inc( Exp) Net- Non- Op Total	-1.63	-1.51	-1.93	-1.29
Diluted Net Income	42.42	36.44	30.72	24.83
Provisionfor Income Taxes	14.55	12.32	10.34	9.47
period Type	-	-	-	-
Net Income Before Extra Items	46.99	36.44	30.72	24.83
Total Revenue	362.36	295.71	227.11	183.84
period Length	12.00	12.00	12.00	12.00
Revenue	362.36	295.71	227.11	183.84
Selling/ General/ Admin Expenses Total	75.78	54.60	43.69	28.89
Diluted Normalized EPS	46.55	36.10	30.43	24.60
Diluted EPS Excluding Extra Ord Items	46.55	36.10	30.43	24.60
Gain( Loss)on Saleof Assets	-	0.00	0.00	0.00
Other Operating Expenses Total	-	0.00	0.00	0.00
Unusual Expense( Income)	-	0.00	0.00	0.00

*All figures in crores except per share values

362.35+23.50(6.94%)

1,122.90+27.30(2.49%)

1,816.90+43.70(2.46%)

1,337.00-24.75 (-1.82%)

4,055.95-74.25 (-1.80%)

Related News